- CEO
- Gan Kim Hai
- Sector
- Financial Services
- Industry
- Financial - Conglomerates
- Address
- 500 5th Avenue New York City NY United States of America 10110
- IPO Date
- Jan 19, 2023
- Business
- AlphaTime Acquisition Corp Right (ATMCR) represents the publicly traded rights of AlphaTime Acquisition Corp, a blank check company or special purpose acquisition company focused on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses; it currently conducts no significant operations of its own and maintains a trust account with IPO proceeds for potential deployment in such transactions. Incorporated in September 2021 and headquartered at 500 5th Avenue, Suite 938, New York, New York, the company primarily targets opportunities in Asia across sectors including fintech, alternative and clean energy, biotechnology, logistics, industrial software, artificial intelligence, and cloud technologies; its securities, comprising ordinary shares (ATMC), units (ATMCU), rights (ATMCR), and warrants (ATMCW), trade on the Nasdaq Capital Market following a transfer effective July 11, 2025, after regaining compliance with Nasdaq Listing Rule 5450(a)(2). Main products encompass these SPAC securities structured to incentivize investor participation in the initial public offering priced at $10 per unit in December 2022, with each unit including one ordinary share, one-half redeemable warrant, and one right convertible to one-tenth of an ordinary share upon a successful business combination; recent developments include the January 2024 announcement of a merger agreement with Hong Kong-based HCYC Group Company Limited, an insurance broker, involving multi-step mergers to create a new public entity (PubCo) with HCYC as a subsidiary, alongside a September 2025 $11.5 million PIPE financing of ordinary shares and warrants to support the transaction, extensions of the business combination deadline in October 2023, adjournments of shareholder meetings in December 2023, closure of a full over-allotment option in January 2023, and separate trading of its securities commencing January 19, 2023.